Summary of Study ST000382
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000299. The data can be accessed directly via it's Project DOI: 10.21228/M8D60P This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST000382 |
Study Title | Urinary Metabolites in IC/PBS Diagnosis (part II) |
Study Type | Disease |
Study Summary | This West Coast Metabolomics Center sponsored pilot grant goal is to identify and validate interstitial cystitis/painful bladder syndrome (IC/PBS)-associated urinary metabolites. Our central hypothesis is that IC/PBS-associated metabolites in the urine of IC/PBS patients can segregate patients from control subjects, and that their levels are correlated with clinical symptoms. To test this hypothesis, we will identify IC/PBS-associated metabolites in urine using two independent platforms, GC-MS and quadrupole time-of-flight (Q-TOF) mass spectrometry under the collaboration with UC Davis WCMC scientists. We believe that this study will provide a significant potential clinical impact because results may lead to clinical methods to increase diagnostic accuracy and an improved understanding of the molecular basis of IC/PBS and its relationship to urologic conditions with overlapping symptoms. |
Institute | University of California, Davis |
Department | Genome and Biomedical Sciences Facility |
Laboratory | WCMC Metabolomics Core |
Last Name | Fiehn |
First Name | Oliver |
Address | Health Sciences Drive, Davis, California, 95616, USA |
ofiehn@ucdavis.edu | |
Phone | (530) 754-8258 |
Raw Data Available | Yes |
Raw Data File Type(s) | d |
Analysis Type Detail | LC-MS |
Release Date | 2016-04-25 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR000299 |
Project DOI: | doi: 10.21228/M8D60P |
Project Title: | Urinary Metabolites in IC/PBS Diagnosis |
Project Summary: | This West Coast Metabolomics Center sponsored pilot grant goal is to identify and validate interstitial cystitis/painful bladder syndrome (IC/PBS)-associated urinary metabolites. Our central hypothesis is that IC/PBS-associated metabolites in the urine of IC/PBS patients can segregate patients from control subjects, and that their levels are correlated with clinical symptoms. To test this hypothesis, we will identify IC/PBS-associated metabolites in urine using two independent platforms, GC-MS and quadrupole time-of-flight (Q-TOF) mass spectrometry under the collaboration with UC Davis WCMC scientists. We believe that this study will provide a significant potential clinical impact because results may lead to clinical methods to increase diagnostic accuracy and an improved understanding of the molecular basis of IC/PBS and its relationship to urologic conditions with overlapping symptoms. |
Institute: | University of California, Davis |
Last Name: | Fiehn |
First Name: | Oliver |
Address: | 1315 Genome and Biomedical Sciences Facility, 451 Health Sciences Drive, Davis, CA 95616 |
Email: | ofiehn@ucdavis.edu |
Phone: | (530) 754-8258 |
Funding Source: | NIH U24DK097154 |
Subject:
Subject ID: | SU000403 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Species Group: | Mammals |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Cohort | Treatment | SubCondition |
---|---|---|---|---|
SA017325 | Inj029_SA090_KimUrine.d | CSMC | IC/PBS Urine | SEVERE |
SA017326 | Inj080_SA092_KimUrine.d | CSMC | IC/PBS Urine | SEVERE |
SA017327 | Inj031_SA089_KimUrine.d | CSMC | IC/PBS Urine | SEVERE |
SA017328 | Inj087_SA087_KimUrine.d | CSMC | IC/PBS Urine | SEVERE |
SA017329 | Inj024_SA086_KimUrine.d | CSMC | IC/PBS Urine | SEVERE |
SA017330 | Inj067_SA093_KimUrine.d | CSMC | IC/PBS Urine | SEVERE |
SA017331 | Inj075_SA088_KimUrine.d | CSMC | IC/PBS Urine | SEVERE |
SA017332 | Inj093_SA091_KimUrine.d | CSMC | IC/PBS Urine | SEVERE |
SA017333 | Inj042_SA098_KimUrine.d | CSMC | IC/PBS Urine | SEVERE |
SA017334 | Inj001_SA099_KimUrine.d | CSMC | IC/PBS Urine | SEVERE |
SA017335 | Inj040_SA094_KimUrine.d | CSMC | IC/PBS Urine | SEVERE |
SA017336 | Inj050_SA097_KimUrine.d | CSMC | IC/PBS Urine | SEVERE |
SA017337 | Inj043_SA100_KimUrine.d | CSMC | IC/PBS Urine | SEVERE |
SA017338 | Inj008_SA096_KimUrine.d | CSMC | IC/PBS Urine | SEVERE |
SA017339 | Inj041_SA095_KimUrine.d | CSMC | IC/PBS Urine | SEVERE |
SA017340 | Inj047_SA075_KimUrine.d | CSMC | Matched Control Urine | n/a |
SA017341 | Inj059_SA077_KimUrine.d | CSMC | Matched Control Urine | n/a |
SA017342 | Inj072_SA076_KimUrine.d | CSMC | Matched Control Urine | n/a |
SA017343 | Inj081_SA074_KimUrine.d | CSMC | Matched Control Urine | n/a |
SA017344 | Inj002_SA072_KimUrine.d | CSMC | Matched Control Urine | n/a |
SA017345 | Inj023_SA078_KimUrine.d | CSMC | Matched Control Urine | n/a |
SA017346 | Inj039_SA071_KimUrine.d | CSMC | Matched Control Urine | n/a |
SA017347 | Inj074_SA073_KimUrine.d | CSMC | Matched Control Urine | n/a |
SA017348 | Inj015_SA084_KimUrine.d | CSMC | Matched Control Urine | n/a |
SA017349 | Inj044_SA079_KimUrine.d | CSMC | Matched Control Urine | n/a |
SA017350 | Inj026_SA085_KimUrine.d | CSMC | Matched Control Urine | n/a |
SA017351 | Inj062_SA082_KimUrine.d | CSMC | Matched Control Urine | n/a |
SA017352 | Inj005_SA083_KimUrine.d | CSMC | Matched Control Urine | n/a |
SA017353 | Inj073_SA081_KimUrine.d | CSMC | Matched Control Urine | n/a |
SA017354 | Inj091_SA080_KimUrine.d | CSMC | Matched Control Urine | n/a |
SA017355 | Inj032_SA065_KimUrine.d | INHA | IC/PBS Urine | INTERMEDIATE |
SA017356 | Inj088_SA057_KimUrine.d | INHA | IC/PBS Urine | INTERMEDIATE |
SA017357 | Inj063_SA067_KimUrine.d | INHA | IC/PBS Urine | INTERMEDIATE |
SA017358 | Inj003_SA049_KimUrine.d | INHA | IC/PBS Urine | INTERMEDIATE |
SA017359 | Inj070_SA070_KimUrine.d | INHA | IC/PBS Urine | INTERMEDIATE |
SA017360 | Inj017_SA069_KimUrine.d | INHA | IC/PBS Urine | INTERMEDIATE |
SA017361 | Inj035_SA054_KimUrine.d | INHA | IC/PBS Urine | INTERMEDIATE |
SA017362 | Inj085_SA035_KimUrine.d | INHA | IC/PBS Urine | INTERMEDIATE |
SA017363 | Inj055_SA031_KimUrine.d | INHA | IC/PBS Urine | INTERMEDIATE |
SA017364 | Inj037_SA068_KimUrine.d | INHA | IC/PBS Urine | MODEST |
SA017365 | Inj033_SA040_KimUrine.d | INHA | IC/PBS Urine | MODEST |
SA017366 | Inj045_SA064_KimUrine.d | INHA | IC/PBS Urine | MODEST |
SA017367 | Inj082_SA060_KimUrine.d | INHA | IC/PBS Urine | MODEST |
SA017368 | Inj038_SA039_KimUrine.d | INHA | IC/PBS Urine | MODEST |
SA017369 | Inj027_SA045_KimUrine.d | INHA | IC/PBS Urine | MODEST |
SA017370 | Inj058_SA032_KimUrine.d | INHA | IC/PBS Urine | MODEST |
SA017371 | Inj086_SA034_KimUrine.d | INHA | IC/PBS Urine | MODEST |
SA017372 | Inj018_SA059_KimUrine.d | INHA | IC/PBS Urine | MODEST |
SA017373 | Inj061_SA038_KimUrine.d | INHA | IC/PBS Urine | MODEST |
SA017374 | Inj092_SA036_KimUrine.d | INHA | IC/PBS Urine | MODEST |
SA017375 | Inj079_SA044_KimUrine.d | INHA | IC/PBS Urine | MODEST |
SA017376 | Inj065_SA053_KimUrine.d | INHA | IC/PBS Urine | MODEST |
SA017377 | Inj016_SA052_KimUrine.d | INHA | IC/PBS Urine | MODEST |
SA017378 | Inj071_SA051_KimUrine.d | INHA | IC/PBS Urine | MODEST |
SA017379 | Inj054_SA048_KimUrine.d | INHA | IC/PBS Urine | MODEST |
SA017380 | Inj013_SA055_KimUrine.d | INHA | IC/PBS Urine | MODEST |
SA017381 | Inj083_SA058_KimUrine.d | INHA | IC/PBS Urine | SEVERE |
SA017382 | Inj094_SA029_KimUrine.d | INHA | IC/PBS Urine | SEVERE |
SA017383 | Inj084_SA028_KimUrine.d | INHA | IC/PBS Urine | SEVERE |
SA017384 | Inj060_SA050_KimUrine.d | INHA | IC/PBS Urine | SEVERE |
SA017385 | Inj014_SA046_KimUrine.d | INHA | IC/PBS Urine | SEVERE |
SA017386 | Inj053_SA033_KimUrine.d | INHA | IC/PBS Urine | SEVERE |
SA017387 | Inj048_SA047_KimUrine.d | INHA | IC/PBS Urine | SEVERE |
SA017388 | Inj012_SA037_KimUrine.d | INHA | IC/PBS Urine | SEVERE |
SA017389 | Inj052_SA030_KimUrine.d | INHA | IC/PBS Urine | SEVERE |
SA017390 | Inj025_SA062_KimUrine.d | INHA | IC/PBS Urine | SEVERE |
SA017391 | Inj089_SA061_KimUrine.d | INHA | IC/PBS Urine | SEVERE |
SA017392 | Inj030_SA056_KimUrine.d | INHA | IC/PBS Urine | SEVERE |
SA017393 | Inj078_SA063_KimUrine.d | INHA | IC/PBS Urine | SEVERE |
SA017394 | Inj022_SA043_KimUrine.d | INHA | IC/PBS Urine | SEVERE |
SA017395 | Inj010_SA042_KimUrine.d | INHA | IC/PBS Urine | SEVERE |
SA017396 | Inj019_SA041_KimUrine.d | INHA | IC/PBS Urine | SEVERE |
SA017397 | Inj064_SA066_KimUrine.d | INHA | IC/PBS Urine | SEVERE |
SA017398 | Inj007_SA013_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017399 | Inj049_SA014_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017400 | Inj034_SA016_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017401 | Inj004_SA012_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017402 | Inj090_SA015_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017403 | Inj006_SA010_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017404 | Inj077_SA017_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017405 | Inj057_SA008_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017406 | Inj009_SA009_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017407 | Inj068_SA011_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017408 | Inj021_SA022_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017409 | Inj046_SA024_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017410 | Inj028_SA025_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017411 | Inj069_SA026_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017412 | Inj011_SA027_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017413 | Inj036_SA023_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017414 | Inj076_SA007_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017415 | Inj051_SA019_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017416 | Inj066_SA020_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017417 | Inj056_SA021_KimUrine.d | INHA | Matched Control Urine | n/a |
SA017418 | Inj020_SA018_KimUrine.d | INHA | Matched Control Urine | n/a |
Showing results 1 to 94 of 94 |
Collection:
Collection ID: | CO000397 |
Collection Summary: | All urine specimens were collected in the morning by clean catch methods. Samples were centrifuged at 4◦C to remove cell debris, and supernatants were aliquots of 1ml/tube, before storage at −80◦C until further analysis. |
Sample Type: | Urine |
Treatment:
Treatment ID: | TR000417 |
Treatment Summary: | Matched control urine vs. IC/PBS Urine |
Sample Preparation:
Sampleprep ID: | SP000410 |
Sampleprep Summary: | 1. The dry sample is resuspended in 50 uL of Water/acetonitrile 95:5 containing 100 ng/mL of CUDA (12-[[(cyclohexylamino)carbonyl]amino]-dodecanoic acid) as internal standard, vortexed for 10 sec, sonicated for 5 minutes, then centrifuged for 3 min at 14,000 rcf. 2. The samples are transferred to amber vials with micro-inserts and capped immediately, and stored at 4 degree C until and during analysis |
Sampleprep Protocol Filename: | SP_RP18_Protocol_KimUrine_IG102814.docx |
Combined analysis:
Analysis ID | AN000616 | AN000617 |
---|---|---|
Analysis type | MS | MS |
Chromatography type | Reversed phase | Reversed phase |
Chromatography system | Agilent 1290 Infinity | Agilent 1290 Infinity |
Column | Waters Acquity BEH C18 (100 x 2.1mm,1.7um) | Waters Acquity BEH C18 (100 x 2.1mm,1.7um) |
MS Type | ESI | ESI |
MS instrument type | QTOF | QTOF |
MS instrument name | Agilent 6530 QTOF | Agilent 6530 QTOF |
Ion Mode | POSITIVE | NEGATIVE |
Units | counts | counts |
Chromatography:
Chromatography ID: | CH000442 |
Instrument Name: | Agilent 1290 Infinity |
Column Name: | Waters Acquity BEH C18 (100 x 2.1mm,1.7um) |
Column Pressure: | 1200 bar |
Column Temperature: | 65 C |
Flow Gradient: | 0% B to 99%B |
Flow Rate: | 0.5 mL/min |
Internal Standard: | CUDA |
Sample Injection: | 3uL |
Solvent A: | 95% water/5% acetonitrile; 0.1% acetic acid |
Solvent B: | 100% acetonitrile; 0.1% acetic acid |
Analytical Time: | 15 min |
Target Sample Temperature: | Autosampler temp 4 C |
Randomization Order: | Excel generated |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS000549 |
Analysis ID: | AN000616 |
Instrument Name: | Agilent 6530 QTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
Ion Mode: | POSITIVE |
Capillary Voltage: | 3500 |
Collision Gas: | Nitrogen |
Dry Gas Flow: | 8 L/min |
Dry Gas Temp: | 325 C |
Fragment Voltage: | 120 |
Fragmentation Method: | Auto MS/MS |
Ion Source Temperature: | 325 C |
Ion Spray Voltage: | 1000 |
Ionization: | Pos |
Precursor Type: | Intact Molecule |
Reagent Gas: | Nitrogen |
Source Temperature: | 325 C |
Dataformat: | .d |
Desolvation Gas Flow: | 11 L/min |
Desolvation Temperature: | 350 C |
Nebulizer: | 35 psig |
Octpole Voltage: | 750 |
Resolution Setting: | extended dynamic range |
Scan Range Moverz: | 60-1700 Da |
Scanning Cycle: | 2 Hz |
Scanning Range: | 60-1700 Da |
Skimmer Voltage: | 65 |
MS ID: | MS000550 |
Analysis ID: | AN000617 |
Instrument Name: | Agilent 6530 QTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
Ion Mode: | NEGATIVE |
Capillary Voltage: | 3500 |
Collision Gas: | Nitrogen |
Dry Gas Flow: | 13 L/min |
Dry Gas Temp: | 200 C |
Fragment Voltage: | 175 |
Fragmentation Method: | Auto MS/MS |
Ion Source Temperature: | 325 C |
Ion Spray Voltage: | 1000 |
Ionization: | Neg |
Dataformat: | .d |
Desolvation Gas Flow: | 11 L/min |
Desolvation Temperature: | 350 C |
Nebulizer: | 35 psig |
Octpole Voltage: | 750 |
Scan Range Moverz: | 60-1700 Da |
Scanning Cycle: | 2Hz |
Scanning Range: | 60-1700 |
Skimmer Voltage: | 65 |